Identification of Biomarkers for Diagnosis and Prognosis of Congenital and Acute Toxoplasmosis

Background. The diagnosis of congenital toxoplasmosis can be inconclusive in many cases. Despite the several serological tests developed, the literature on biomarkers that can assist in the diagnosis of congenital an acute toxoplasmosis is limited. The objective of this study was to analyze the immunoreactive profile of Toxoplasma gondii protein bands with the potential to be biomarkers for diagnosis and prognosis of congenital and acute toxoplasmosis. Methods. Peripheral blood samples from women of childbearing age and/or pregnant women diagnosed with acquired toxoplasmosis as well as from congenitally infected children were selected and submitted to immunoblotting for analysis of the immunoreactive bands profile by immunoglobulin G (IgG) antibodies. Results. When comparing the immunoreactive bands profile for antibodies present in samples from different groups and subgroups, the 150, 18.5, and 16.96-kDa bands were more immunoreactive with the antibodies present in serum samples from the acquired infection group. The 343, 189, 150, 75, and 42-10a bands showed more chance to be detected by the symptomatic congenital infection subgroup samples, while the 61, 50, and 16.96-kDa bands were significantly immunoreactive with the acute infection subgroup samples. Conclusions. The identification of these potential biomarkers can assist in early diagnosis and treatment of congenital toxoplasmosis.

Automated summary

This study analyzed the immunoreactive profile of Toxoplasma gondii protein bands to identify potential biomarkers for the diagnosis and prognosis of congenital and acute toxoplasmosis. Specific bands were found to be more immunoreactive in samples from different groups and subgroups, potentially aiding in the early detection and treatment of congenital toxoplasmosis.